<p>Wedge Capital Management L L P NC 在最近向美国证券交易委员会提交的 13F 表格中披露，在第三季度收购了 Pediatrix Medical Group, Inc.（纽约证券交易所代码：MD - 免费报告）的新股份。该基金收购了 138,228 股公司股票，价值约为 2,315,000 美元。Wedge Capital Management L L P NC 在最近一个季度末持有 Pediatrix Medical Group 0.16% 的股份。</p>
<ul>
<li>美敦力股票找到立足点——现在正在获得动能</li>
</ul>
<p>其他几家机构投资者和对冲基金最近也调整了对 MD 的持股。Voya Investment Management LLC 在第三季度将其在 Pediatrix Medical Group 的股份增加了 62.4%。Voya Investment Management LLC 目前持有 39,132 股公司股票，价值 655,000 美元，在此期间又购买了 15,030 股。Squarepoint Ops LLC 在第二季度将其在 Pediatrix Medical Group 的股份增加了 234.6%。Squarepoint Ops LLC 目前持有 81,142 股公司股票，价值 1,164,000 美元，在上个季度又收购了 56,889 股。野村控股公司在第二季度将其在 Pediatrix Medical Group 的持股增加了 121.4%。野村控股公司目前持有 576,730 股公司股票，价值 8,276,000 美元，在此期间又收购了 316,274 股。Caxton Associates LLP 在第二季度购买了 Pediatrix Medical Group 的新股份，价值约为 236,000 美元。最后，公共部门养老金投资委员会在第二季度将其在 Pediatrix Medical Group 的股份增加了 7.1%。公共部门养老金投资委员会目前持有 287,060 股公司股票，价值 4,119,000 美元，在上个季度又收购了 18,984 股。97.71% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票研究分析师最近对 MD 股票发表了看法。华尔街 Zen 在 10 月 4 日的研究报告中将 Pediatrix Medical Group 的评级从 “买入” 上调至 “强力买入”。Truist Financial 在 11 月 10 日的研究报告中将 Pediatrix Medical Group 的目标股价从 17.00 美元提高至 24.00 美元，并给予该股票 “持有” 评级。Zacks Research 在 11 月 21 日的研究报告中将 Pediatrix Medical Group 的评级从 “持有” 上调至 “强力买入”。Leerink Partners 在 9 月 5 日的报告中将 Pediatrix Medical Group 的目标股价从 14.50 美元提高至 17.00 美元，并给予该股票 “市场表现” 评级。最后，Weiss Ratings 在周一的研究报告中重申了对 Pediatrix Medical Group 的 “持有（c+）” 评级。一位投资分析师对该股票给予了强力买入评级，一位给予了买入评级，四位给予了持有评级。根据 MarketBeat 的数据，该公司的共识评级为 “适度买入”，平均目标价为 21.00 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p><strong>阅读我们关于 Pediatrix Medical Group 的最新报告</strong></p>
<h2>内部人士下注</h2>
<p>在其他 Pediatrix Medical Group 的新闻中，董事 Michael A. Rucker 于 11 月 17 日星期一出售了 10,478 股 Pediatrix Medical Group 股票。股票以平均价格 23.00 美元出售，总价值为 240,994.00 美元。出售完成后，该董事持有 59,101 股公司股票，价值约为 1,359,323 美元。此次交易使其持股减少了 15.06%。该交易已在向美国证券交易委员会提交的文件中披露，您可以通过此超链接访问。此外，首席执行官 Mark S. Ordan 于 12 月 15 日星期一出售了 23,000 股该股票。股票以平均价格 22.41 美元出售，总价值为 515,430.00 美元。交易完成后，首席执行官直接持有 302,805 股公司股票，价值 6,785,860.05 美元。此次交易使其持股减少了 7.06%。该销售的 SEC 文件提供了更多信息。在上个季度，内部人士出售了价值 972,924 美元的 43,478 股公司股票。公司内部人士持有 0.90% 的公司股票。</p>
<h2>Pediatrix Medical Group 股票下跌 2.5%</h2>
<ul>
<li>美敦力：收入投资者的机会变得更健康</li>
</ul>
<p>纽约证券交易所：MD 周三开盘价为 21.45 美元。该公司的市值为 18.4 亿美元，市盈率为 11.29，贝塔值为 0.77。该公司的债务与股本比率为 0.65，速动比率为 1.83，流动比率为 1.83。Pediatrix Medical Group, Inc. 的 52 周低点为 11.84 美元，52 周高点为 24.99 美元。该公司的 50 日简单移动平均为 21.18 美元，200 日简单移动平均为 17.17 美元。</p>
<p>Pediatrix Medical Group（纽约证券交易所：MD - 获取免费报告）最近于 11 月 3 日星期一发布了其财报。该公司报告本季度每股收益（EPS）为 0.67 美元，超出市场共识预期的 0.46 美元，超出幅度为 0.21 美元。该公司本季度的收入为 4.9288 亿美元，而市场共识预期为 4.7645 亿美元。Pediatrix Medical Group 的净利润率为 8.44%，股本回报率为 20.45%。该公司的收入同比下降了 3.6%。在去年同期，该公司每股收益为 0.44 美元。分析师预测 Pediatrix Medical Group, Inc. 本财年将发布 1.38 美元的每股收益。</p>
<h2>Pediatrix Medical Group 简介</h2>
<p>（免费报告）</p>
<p>Pediatrix Medical Group, Inc NYSE: MD 是一家全国性的由医生主导的医疗集团，专注于高危新生儿、母胎及儿科专业护理。公司总部位于佛罗里达州的阳光城，通过医院基础的医生配备、高级从业者支持和远程医疗项目提供临床服务。其核心专业包括新生儿医学、母胎医学、儿科心脏病学、儿科重症监护、儿科急救医学和麻醉学。</p>
<p>公司成立于 1979 年，前身为 MEDNAX，2022 年更名为 Pediatrix Medical Group，以使其企业形象与主要临床服务相一致。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过 Pediatrix Medical Group</li>
<li>持续带来收益的礼物（今天只需 1 美元）</li>
<li>这个假期你花的最值得的 1 美元</li>
<li>特朗普做了什么？？</li>
<li>可能每月带来 4290 美元收益的无聊 AI 投资</li>
<li>特朗普的 “美国房地产交易” 解读</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Pediatrix Medical Group 吗？</h2>
<p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Pediatrix Medical Group 并不在名单上。</p>
<p>虽然 Pediatrix Medical Group 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Wedge Capital Management L L P NC 收购了 138,228 股 Pediatrix Medical Group，价值 231.5 万美元。其他机构投资者也增加了他们的持股。分析师对该股票给予了 “适度买入” 的共识评级，目标价格为 21.00 美元。最近的内部销售包括 43,478 股，价值 972,924 美元。该股票开盘价为 21.45 美元，市值为 18.4 亿美元</p>

<p>Wedge Capital Management L L P NC acquired a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 138,228 shares of the company's stock, valued at approximately $2,315,000. Wedge Capital Management L L P NC owned 0.16% of Pediatrix Medical Group at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Wedge Capital Management L L P NC 在最近向美国证券交易委员会提交的 13F 表格中披露，在第三季度收购了 Pediatrix Medical Group, Inc.（纽约证券交易所代码：MD - 免费报告）的新股份。该基金收购了 138,228 股公司股票，价值约为 2,315,000 美元。Wedge Capital Management L L P NC 在最近一个季度末持有 Pediatrix Medical Group 0.16% 的股份。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到立足点——现在正在获得动能</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also recently modified their holdings of MD. Voya Investment Management LLC increased its position in shares of Pediatrix Medical Group by 62.4% during the third quarter. Voya Investment Management LLC now owns 39,132 shares of the company's stock valued at $655,000 after buying an additional 15,030 shares during the period. Squarepoint Ops LLC boosted its position in Pediatrix Medical Group by 234.6% during the 2nd quarter. Squarepoint Ops LLC now owns 81,142 shares of the company's stock valued at $1,164,000 after acquiring an additional 56,889 shares in the last quarter. Nomura Holdings Inc. grew its holdings in shares of Pediatrix Medical Group by 121.4% during the 2nd quarter. Nomura Holdings Inc. now owns 576,730 shares of the company's stock worth $8,276,000 after acquiring an additional 316,274 shares during the period. Caxton Associates LLP bought a new position in shares of Pediatrix Medical Group in the 2nd quarter worth approximately $236,000. Finally, Public Sector Pension Investment Board raised its position in shares of Pediatrix Medical Group by 7.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 287,060 shares of the company's stock worth $4,119,000 after acquiring an additional 18,984 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金最近也调整了对 MD 的持股。Voya Investment Management LLC 在第三季度将其在 Pediatrix Medical Group 的股份增加了 62.4%。Voya Investment Management LLC 目前持有 39,132 股公司股票，价值 655,000 美元，在此期间又购买了 15,030 股。Squarepoint Ops LLC 在第二季度将其在 Pediatrix Medical Group 的股份增加了 234.6%。Squarepoint Ops LLC 目前持有 81,142 股公司股票，价值 1,164,000 美元，在上个季度又收购了 56,889 股。野村控股公司在第二季度将其在 Pediatrix Medical Group 的持股增加了 121.4%。野村控股公司目前持有 576,730 股公司股票，价值 8,276,000 美元，在此期间又收购了 316,274 股。Caxton Associates LLP 在第二季度购买了 Pediatrix Medical Group 的新股份，价值约为 236,000 美元。最后，公共部门养老金投资委员会在第二季度将其在 Pediatrix Medical Group 的股份增加了 7.1%。公共部门养老金投资委员会目前持有 287,060 股公司股票，价值 4,119,000 美元，在上个季度又收购了 18,984 股。97.71% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities research analysts recently weighed in on MD shares. Wall Street Zen raised Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, October 4th. Truist Financial increased their price target on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a &#34;hold&#34; rating in a research note on Monday, November 10th. Zacks Research raised shares of Pediatrix Medical Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, November 21st. Leerink Partners upped their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a &#34;market perform&#34; rating in a report on Friday, September 5th. Finally, Weiss Ratings reaffirmed a &#34;hold (c+)&#34; rating on shares of Pediatrix Medical Group in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $21.00.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 MD 股票发表了看法。华尔街 Zen 在 10 月 4 日的研究报告中将 Pediatrix Medical Group 的评级从 “买入” 上调至 “强力买入”。Truist Financial 在 11 月 10 日的研究报告中将 Pediatrix Medical Group 的目标股价从 17.00 美元提高至 24.00 美元，并给予该股票 “持有” 评级。Zacks Research 在 11 月 21 日的研究报告中将 Pediatrix Medical Group 的评级从 “持有” 上调至 “强力买入”。Leerink Partners 在 9 月 5 日的报告中将 Pediatrix Medical Group 的目标股价从 14.50 美元提高至 17.00 美元，并给予该股票 “市场表现” 评级。最后，Weiss Ratings 在周一的研究报告中重申了对 Pediatrix Medical Group 的 “持有（c+）” 评级。一位投资分析师对该股票给予了强力买入评级，一位给予了买入评级，四位给予了持有评级。根据 MarketBeat 的数据，该公司的共识评级为 “适度买入”，平均目标价为 21.00 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p><strong>Read Our Latest Report on Pediatrix Medical Group</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Pediatrix Medical Group 的最新报告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Pediatrix Medical Group news, Director Michael A. Rucker sold 10,478 shares of Pediatrix Medical Group stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $23.00, for a total value of $240,994.00. Following the completion of the sale, the director owned 59,101 shares of the company's stock, valued at approximately $1,359,323. The trade was a 15.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Mark S. Ordan sold 23,000 shares of the stock in a transaction on Monday, December 15th. The shares were sold at an average price of $22.41, for a total value of $515,430.00. Following the transaction, the chief executive officer directly owned 302,805 shares in the company, valued at $6,785,860.05. The trade was a 7.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 43,478 shares of company stock valued at $972,924. Company insiders own 0.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Pediatrix Medical Group 的新闻中，董事 Michael A. Rucker 于 11 月 17 日星期一出售了 10,478 股 Pediatrix Medical Group 股票。股票以平均价格 23.00 美元出售，总价值为 240,994.00 美元。出售完成后，该董事持有 59,101 股公司股票，价值约为 1,359,323 美元。此次交易使其持股减少了 15.06%。该交易已在向美国证券交易委员会提交的文件中披露，您可以通过此超链接访问。此外，首席执行官 Mark S. Ordan 于 12 月 15 日星期一出售了 23,000 股该股票。股票以平均价格 22.41 美元出售，总价值为 515,430.00 美元。交易完成后，首席执行官直接持有 302,805 股公司股票，价值 6,785,860.05 美元。此次交易使其持股减少了 7.06%。该销售的 SEC 文件提供了更多信息。在上个季度，内部人士出售了价值 972,924 美元的 43,478 股公司股票。公司内部人士持有 0.90% 的公司股票。</p>
</div><h2>Pediatrix Medical Group Stock Down 2.5%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票下跌 2.5%</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更健康</li>
</ul>
</div><p>NYSE:MD opened at $21.45 on Wednesday. The firm has a market cap of $1.84 billion, a P/E ratio of 11.29 and a beta of 0.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.83 and a current ratio of 1.83. Pediatrix Medical Group, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $24.99. The firm has a 50-day simple moving average of $21.18 and a two-hundred day simple moving average of $17.17.</p>
<div class="lb-trans"><p>纽约证券交易所：MD 周三开盘价为 21.45 美元。该公司的市值为 18.4 亿美元，市盈率为 11.29，贝塔值为 0.77。该公司的债务与股本比率为 0.65，速动比率为 1.83，流动比率为 1.83。Pediatrix Medical Group, Inc. 的 52 周低点为 11.84 美元，52 周高点为 24.99 美元。该公司的 50 日简单移动平均为 21.18 美元，200 日简单移动平均为 17.17 美元。</p>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.21. The firm had revenue of $492.88 million for the quarter, compared to the consensus estimate of $476.45 million. Pediatrix Medical Group had a net margin of 8.44% and a return on equity of 20.45%. The business's revenue was down 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 earnings per share. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group（纽约证券交易所：MD - 获取免费报告）最近于 11 月 3 日星期一发布了其财报。该公司报告本季度每股收益（EPS）为 0.67 美元，超出市场共识预期的 0.46 美元，超出幅度为 0.21 美元。该公司本季度的收入为 4.9288 亿美元，而市场共识预期为 4.7645 亿美元。Pediatrix Medical Group 的净利润率为 8.44%，股本回报率为 20.45%。该公司的收入同比下降了 3.6%。在去年同期，该公司每股收益为 0.44 美元。分析师预测 Pediatrix Medical Group, Inc. 本财年将发布 1.38 美元的每股收益。</p>
</div><h2>Pediatrix Medical Group Profile</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc NYSE: MD 是一家全国性的由医生主导的医疗集团，专注于高危新生儿、母胎及儿科专业护理。公司总部位于佛罗里达州的阳光城，通过医院基础的医生配备、高级从业者支持和远程医疗项目提供临床服务。其核心专业包括新生儿医学、母胎医学、儿科心脏病学、儿科重症监护、儿科急救医学和麻醉学。</p>
</div><p>Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.</p>
<div class="lb-trans"><p>公司成立于 1979 年，前身为 MEDNAX，2022 年更名为 Pediatrix Medical Group，以使其企业形象与主要临床服务相一致。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>The gift that keeps giving (just $1 today)</li>
<li>The Best $1 You'll Spend This Holiday Season</li>
<li>Trump Did WHAT??</li>
<li>The boring AI play that could pay up to $4,290 monthly</li>
<li>Trump’s “real estate deal for America” explained</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Pediatrix Medical Group</li>
<li>持续带来收益的礼物（今天只需 1 美元）</li>
<li>这个假期你花的最值得的 1 美元</li>
<li>特朗普做了什么？？</li>
<li>可能每月带来 4290 美元收益的无聊 AI 投资</li>
<li>特朗普的 “美国房地产交易” 解读</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Pediatrix Medical Group 吗？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Pediatrix Medical Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Pediatrix Medical Group 并不在名单上。</p>
</div><p>While Pediatrix Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Pediatrix Medical Group 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Wedge Capital Management L L P NC 购买了 Pediatrix Medical Group, Inc.的新股票 $MD